tibet rhodiola pharm-a (600211:Shanghai)
Transactions by TIBET RHODIOLA PHARM-A (600211) in the last 6 months
Shenzhen Kangzhe Pharmaceutical Technology Development Co., Ltd. signed an agreement to acquire additional 17.97% stake in Tibet Rhodiola Pharmaceutical Holding Company (SHSE:600211) from Beijing New Phoenix Properties Development Limited, Tibet TongYing Investment Co., Ltd. and Tianjin Tongsheng Investment Co. Ltd. for approximately CNY 780 million in cash on October 29, 2014. The consideration is subject to adjustments. Kangzhe Pharmaceutical will acquire 13.73%, 3.09% ...
|No competitor information is available for 600211.|
|View Industry Companies|